ReviewDrug design, development and therapy2017

Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date.

Alberto GajofattoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.